Individualized Fludarabine-Based Regimen in Elderly Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

被引：0
|
作者：
Bo Guo
Hong-Li Zhu
Hui Fan
Su-Xia Li
Xue-Chun Lu
Jie Lin
Hai-Hong Ran
Bing Zhai
Yang Yang
机构：
[1] General Hospital of People’s Liberation Army,
来源：
Advances in Therapy | 2012年 / 29卷
关键词：
advanced age; chronic lymphocytic leukemia/small lymphocytic lymphoma; fludarabine; individualized regimen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：178 / 186
页数：8
相关论文
共 50 条
  • [31] The Fate of Chronic Lymphocytic Leukemia Patients After Failure of Fludarabine, Cyclophosphamide, and Rituximab Regimen
    Panovska, Anna
    Lysak, Daniel
    Smolej, Lukas
    Brychtova, Yvona
    Simkovic, Martin
    Motyckova, Monika
    Lindtnerova, Michaela
    Trbusek, Martin
    Malcikova, Jitka
    Pospisilova, Sarka
    Mayer, Jiri
    Doubek, Michael
    BLOOD, 2012, 120 (21)
  • [32] Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia
    Francis J. Giles
    Gary Guangping Shi
    Jorge E. Cortes
    Deborah Thomas
    Anna R. Keating
    Hagop M. Kantarjian
    Michael J. Keating
    Susan M. O'Brien
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 223 - 228
  • [33] Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia
    Giles, FJ
    Shi, GGP
    Cortes, JE
    Thomas, D
    Keating, AR
    Kantarjian, HM
    Keating, MJ
    O'Brien, SM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (03) : 223 - 228
  • [34] Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma
    Hainsworth, John D.
    Vazquez, Elizabeth R.
    Spigel, David R.
    Raefsky, Eric
    Bearden, James D.
    Saez, Ruben A.
    Greco, F. Anthony
    CANCER, 2008, 112 (06) : 1288 - 1295
  • [35] Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Kampalath, B
    Barcos, MP
    Stewart, C
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (06) : 824 - 832
  • [36] Optimizing Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Mato, Anthony
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (5.5): : 581 - 583
  • [37] The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Zou, Yi-Xin
    Zhu, Hua-Yuan
    Li, Xiao-Tong
    Xia, Yi
    Miao, Kou-Rong
    Zhao, Si-Shu
    Wu, Yu-Jie
    Wang, Li
    Xu, Wei
    Li, Jian-Yong
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (04) : 392 - 400
  • [38] The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Zou, Yi-Xin
    Zhu, Hua-Yuan
    Li, Xiao-Tong
    Xia, Yi
    Miao, Kou-Rong
    Zhao, Si-Shu
    Wu, Yujie
    Wang, Li
    Xu, Wei
    Li, Jianyong
    LEUKEMIA & LYMPHOMA, 2020, 61 : 5 - 6
  • [39] Symptomatic BK virus reactivation following fludarabine, cyclophosphamide and rituximab chemotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma
    Appleby, Niamh
    Dillon, Anna
    Arrigan, Martin
    Fennell, Jerome
    Crowley, Brendan
    Hayden, Patrick J.
    Enright, Helen
    LEUKEMIA & LYMPHOMA, 2014, 55 (05) : 1181 - 1183
  • [40] Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia with Chromothripsis in an Old Woman
    Tan Li
    Xu Li-Hua
    Liu Hai-Bo
    Yang Shao-Jiang
    中华医学杂志英文版, 2015, 128 (07) : 985 - 987
12345